References
1. Smirnov V.V., Leonov G.E. Epigenetics: theoretical aspects and practical implications. Lechashchiy vrach [Attending Physician]. 2016; (16): 26. (in Russian)
2. Epigenetics. Edit by C.D. АИ1в, T. Jenuwein, D. Reinberg. Moscow: Technosfera, 2010: 496 p. (in Russian)
3. About all RNA in the world, large and small [Electronic resource]. URL: https://biomolecula.ru/articles/obo-vsekh-rnk-na-svete-bolshikh-i-malykh (in Russian)
4. Iorio M.V., Croce C.M. Commentary on microRNA fingerprint in human epithelial ovarian cancer. Cancer Res. 2016; 26 (21): 6143-5.
5. Lazzarini R., et al. From 2646 to 15: differentially regulated microRNAs between progenitors from normal myometrium and leiomyoma. Am J Obstet Gynecol. 2020; 222 (6): 596.e1-9.
6. Chuang T.D., Khorram O. Regulation of cell cycle regulatory proteins by MicroRNAs in uterine leiomyoma. Reprod Sci. 2019; 26 (2): 250-8.
7. Nothnick W.B. Non-coding RNAs in uterine development, function and disease. Adv Exp Med Biol. 2016; 886: 171-89.
8. Pardini B., De Maria D., Francavilla A., Di Gaetano C., Ronco G., Nac-carati A. MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer. 2018; 18 (1): 696.
9. Arkhangelskaya P.A., Bakhidze E.V., Berlev I.V., Samsonov R.B., Ivanov M.K., Malek A.V. MicroRNA, HPV infection and cervical carcinogenesis: molecular aspects and prospects for clinical use. Sibirskiy onko-logicheskiy zhurnal [Siberian Journal of Oncology]. 2016; 15 (4): 88-97. (in Russian)
10. Laengsri V., Kerdpin U., Plabplueng C., et al. Cervical cancer markers: epigenetics and microRNAs. Lab Med. 2018; 49 (2): 97-111.
11. Petrovic N., Davidovic R., Bajic V., Obradovic M., Isenovic R.E. MicroRNA in breast cancer: the association with BRCA1/2. Cancer Biomark. 2017; 19 (2): 119-28.
12. Taipov M.A., Nikiforova Z.N., Laktionov K.P., Levchenko N.E., Shevchenko V.E. MicroRNA MiR-21 and MiR-155 - new markers of breast cancer. Opukholi zhenskoy reproduktivnoy sistemy [Tumors of the Female Reproductive System]. 2013; (3-4): 6-11. (in Russian)
13. Pimentel F., Bonilla P., Ravishankar Y.G., et al. Technology in MicroRNA profiling: circulating microRNAs as noninvasive cancer biomarkers in breast cancer. J Lab Autom. 2015; 20 (5): 574-88.
14. Bertoli G., Cava C., Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015; 5 (10): 1122-43.
15. Hutt S., Tailor A., Ellis P., Michael A., Butler-Manuel S., Chatterjee J. The role of biomarkers in endometrial cancer and hyperplasia: a literature review. Acta Oncol. 2019; 58 (3): 342-52.
16. Delangle R., De Foucher T., Larsen A.K., et al. The use of microRNAs in the management of endometrial cancer: a meta-analysis. Cancers (Basel). 2019; 11 (6): 832.
17. Gilabert-Estelles J., Braza-Boils A., Ramon L.A., Zorio E., Medina P., Espana F., et al. Role of microRNAs in gynecological pathology. Curr Med Chem. 2012; 19: 2406-13.
18. Giglio S., Annibali V., Cirombella R., et al. miRNAs as Candidate biomarker for the accurate detection of atypical endometrial hyperplasia/ endometrial intraepithelial neoplasia. Front Oncol. 2019; 9: 526.
19. Tu J., Cheung A.H., Chan C.L., Chan W.Y. The Role of microRNAs in ovarian granulosa cells in health and disease. Front Endocrinol (Lausanne). 2019; 10: 174.
20. Naji M., Aleyasin A., Nekoonam S., Arefian E., Mahdian R., Amidi F. Differential expression of miR-93 and miR-21 in granulosa cells and follicular fluid of polycystic ovary syndrome associating with different phenotypes. Sci Rep. 2017; 7 (1): 14671.
21. Quezada M., Wang J., Hoang V., McGee E.A. Smad7 is a transforming growth factor-beta-inducible mediator of apoptosis in granulosa cells. Fertil Steril. 2012; 97 (6): 1452-9.
22. Wang M., Liu M., Sun J., Jia L., Ma S., Gao J., et al. MicroRNA-27a-3p affects estradiol and androgen imbalance by targeting Creb1 in the granulosa cells in mouse polycytic ovary syndrome model. Reprod Biol. 2017; 17 (4): 295-304.
23. Ferreira P., Roela R.A., Lopez R.V.M., Del Pilar Estevez-Diz M. The prognostic role of microRNA in epithelial ovarian cancer: a systematic review of literature with an overall survival meta-analysis. Oncotarget. 2020; 11 (12): 1085-95.
24. Biamonte F., Santamaria G., Sacco A., et al. MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer. Sci Rep. 2019; 9 (1): 5668.
25. Chen Y., Zhang L., Hao Q. Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation. Cancer Cell Int. 2013; 13 (1): 86.
26. Teague E.M., Print C.G., Hull M.L. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update. 2010; 16 (2): 142-65.
27. Agrawal S., Tapmeier T., Rahmioglu N., Kirtley S., Zondervan K., Becker C. The miRNA mirage: how close are we to finding a non-invasive diagnostic biomarker in endometriosis? A systematic review. Int J Mol Sci. 2018; 19 (2): 599.
28. URL: https://endometriosisfoundation.org/
29. URL: https://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-targeted-rna-based-therapy-treat-rare-disease/
30. URL: https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials/
31. URL: http://catalog.mit.edu/archive/